Antigenics to Report Second Quarter Financial Results on July 29, 2010; Conference Call to Follow

LEXINGTON, Mass.--(BUSINESS WIRE)-- Antigenics Inc. (NASDAQ: AGEN) will release its second quarter financial results before the market opens on July 29, 2010.

Antigenics executives will host a conference call at 11:00 a.m. Eastern Time that same day. To access the live call, dial 877.762.5772 (domestic) or 706.643.6986 (international); the access code is 87992038. The call will also be webcast and will be accessible from the company’s website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight Eastern Time on January 29, 2011. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 87992038. The replay will also be available on the company’s website approximately two hours after the live call.

Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.antigenics.com.



CONTACT:

Antigenics Inc.
Media:
Brad Miles, 212-477-9007 x17
or
Investors:
Shalini Sharp, 800-962-2436

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Oncology  Pharmaceutical  Professional Services  Finance  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.